학술논문
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma
Document Type
Article
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 March 2017 97(3):487-494
Subject
Language
ISSN
0360-3016